Asuransi Jiwa Valuation
| LIFE Stock | 6,000 225.00 3.90% |
At this time, the firm appears to be overvalued. Asuransi Jiwa Sinarmas shows a prevailing Real Value of USD5285.25 per share. The current price of the firm is USD6000.0. Our model approximates the value of Asuransi Jiwa Sinarmas from analyzing the firm fundamentals such as Current Valuation of 10.43 T, return on equity of 0.027, and Profit Margin of 0.05 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Asuransi Jiwa's price fluctuation is very steady at this time. Calculation of the real value of Asuransi Jiwa Sinarmas is based on 3 months time horizon. Increasing Asuransi Jiwa's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Asuransi Jiwa's intrinsic value may or may not be the same as its current market price of 6,000, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 6000.0 | Real 5285.25 | Hype 5775.0 |
The intrinsic value of Asuransi Jiwa's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Asuransi Jiwa's stock price.
Estimating the potential upside or downside of Asuransi Jiwa Sinarmas helps investors to forecast how Asuransi stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Asuransi Jiwa more accurately as focusing exclusively on Asuransi Jiwa's fundamentals will not take into account other important factors: Asuransi Jiwa Total Value Analysis
Asuransi Jiwa Sinarmas is now forecasted to have takeover price of 10.43 T with market capitalization of 13.23 T, debt of 20.47 B, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Asuransi Jiwa fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
10.43 T | 13.23 T | 20.47 B |
Asuransi Jiwa Investor Information
About 13.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.55. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Asuransi Jiwa Sinarmas recorded earning per share (EPS) of 97.0. The entity last dividend was issued on the 1st of July 2022. The firm had 2:1 split on the 16th of September 2019. Based on the key measurements obtained from Asuransi Jiwa's financial statements, Asuransi Jiwa Sinarmas is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.Asuransi Jiwa Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of Asuransi suggests not a very effective usage of assets in March.Asuransi Jiwa Ownership Allocation
Asuransi Jiwa holds a total of 2.1 Billion outstanding shares. Asuransi Jiwa Sinarmas shows 12.63 percent of its outstanding shares held by insiders and 8.0 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Asuransi Jiwa Profitability Analysis
The company reported the revenue of 4.04 T. Net Income was 73.82 B with profit before overhead, payroll, taxes, and interest of 552.2 B.About Asuransi Jiwa Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Asuransi Jiwa Sinarmas. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Asuransi Jiwa Sinarmas based exclusively on its fundamental and basic technical indicators. By analyzing Asuransi Jiwa's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Asuransi Jiwa's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Asuransi Jiwa. We calculate exposure to Asuransi Jiwa's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Asuransi Jiwa's related companies.8 Steps to conduct Asuransi Jiwa's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Asuransi Jiwa's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Asuransi Jiwa's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Asuransi Jiwa's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Asuransi Jiwa's revenue streams: Identify Asuransi Jiwa's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Asuransi Jiwa's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Asuransi Jiwa's growth potential: Evaluate Asuransi Jiwa's management, business model, and growth potential.
- Determine Asuransi Jiwa's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Asuransi Jiwa's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Other Information on Investing in Asuransi Stock
Asuransi Jiwa financial ratios help investors to determine whether Asuransi Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Asuransi with respect to the benefits of owning Asuransi Jiwa security.